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Abstract. Integrated community casemanagement (iCCM) aims to reduce childmortality in areaswith poor access to
health care. iCCM was implemented in 2009 in Kono district, Sierra Leone, a postconﬂict area with high under-ﬁve
mortality rates (U5MRs). We evaluated iCCM’s impact and effects on child health using cluster surveys in 2010 (midterm)
and 2013 (endline) to compare indicators on child mortality, coverage of appropriate treatment, timely access to care,
quality of care, and recognition of community health workers (CHWs). The sample size was powered to detect a 28%
decline in U5MR. Clusters were selected proportional to population size. All households were sampled to measure
mortality and systematic random sampling was used to measure coverage in a subset of households. We used program
data to evaluate utilization and access; 5,257 (2010) and 3,649 (2013) households were surveyed. U5MR did not change
signiﬁcantly (4.54 [95% conﬁdence interval [CI]: 3.47–5.60] to 3.95 [95% CI: 3.06–4.83] deaths per 1,000 per month (P =
0.4)) though a relative change smaller than 28%could not be detected. CHWswere the ﬁrst source of care for 52% (2010)
and 50.9% (2013) of children. Coverage of appropriate treatment of fever by CHWs or peripheral health units increased
from 45.5% [95%CI: 39.2–52.0] to 58.2% [95%CI: 50.5–65.5] (P = 0.01); changes for diarrhea and pneumonia were not
signiﬁcant. The continued reliance on the CHW as the ﬁrst source of care and improved coverage for the appropriate
treatment of fever support iCCM’s role in Kono district.
INTRODUCTION
At 120.4 deaths per 1,000 live births in 2015, Sierra Leone’s
under-ﬁve mortality rate (U5MR) ranks under only Angola,
Chad, Somalia, and Central African Republic.1 Challenges in
postconﬂict development have resulted in the failure to attain
Millennium Development Goal 4 of reduced child mortality by
2015.2 By the end of its 10-year civil war in 2002, 50,000
persons had died and half of its population was displaced. At
the war’s peak in 1996, only 16% of health centers were op-
erational and were largely concentrated in the capital, Free-
town.3 In 2001, the crudemortality rate (CMR) in an accessible
area of the conﬂict-affected eastern district of Kenema was
1.2 deaths per 10,000 persons per day (95% conﬁdence in-
terval [CI]: 1.05–1.38), exceeding the threshold for a humani-
tarian crisis of one death per 10,000 persons per day.4,5 Most
deaths were attributable to febrile illness and were therefore
preventable; this indicated a collapse of the health system.
Following the war, the national health policy aimed to pro-
vide equitable health-care access through the revitalization
and decentralization of front-line health facilities (called pe-
ripheral health units, or PHUs). In 2010, the Free Health Care
Initiative was initiated to provide care at no cost to children
under-ﬁve, pregnant women, and lactating mothers using the
network of 1,200 PHUs.6,7 However, limited human resources
remained a barrier. Approximately, 880 nurses and 825 ma-
ternal and child health aideswere usedat the community level,
equating to 47% of the total number of community-level
workers needed to meet the workload.8 The lack of health-
care workers able to treat illnesses among children under-ﬁve
continued to contribute to the high mortality.
In 2009, after providing humanitarian relief during the war,
the International Rescue Committee (IRC) supported the
Ministry of Health and Sanitation to develop health programs,
including an integrated community case management (iCCM)
program in the eastern Kono district. The main goal was to
increase access to care for children under-ﬁve. The United
Nations Children’s Fund and World Health Organization rec-
ommend iCCM as a strategy to promote increased and eq-
uitable access to treatment through village-based community
health workers (CHWs) who treat fever, diarrhea, and sus-
pected pneumonia among children aged 2–59 months.9 If
iCCM can target communities with low access to care and
deliver high-quality care to a high proportion of children, then
in principle, rapid reductions in child mortality should follow.10
Although community case management for each condition
has shown efﬁcacy in reducing mortality, few evaluations of
iCCM at scale have been conducted and none have demon-
strated effectiveness in child survival.10–15 Moreover, little is
known about the implementation and effects of iCCM in
strengthening health systems in postconﬂict states, which are
characterized by the degradation of government services and
the workforce coupled with a distrust of services by commu-
nities.16 In 2010, theU5MR inKono, asmeasuredby aMultiple
Indicator Cluster Survey, was slightly higher than the national
rate, 202 versus 217 deaths per 1,000 live births, re-
spectively.17 Health outcomes and health-care access were
poor in 2009. The prevalence of acute malnutrition among
children under-ﬁve was 8.7% and classiﬁed as medium se-
verity of malnutrition prevalence.17,18 Vaccination coverage for
the third diphtheria–pertussis–tetanus dose among children
12–23months of age was low (53%), indicating poor access to
PHUs and/or a low demand for services.17
We measured trends in process and impact indicators to
investigate the effectiveness of iCCM in reducing under-ﬁve
mortality and morbidity, after its introduction in September
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2009. The primary objective was to measure the change in
age-speciﬁc U5MRs at the midterm (in October–November,
2010) and the endline (in January–February, 2013) periods of
an iCCM program which ran from September 2009 to 2013.
The secondary objectives were to measure changes in care-
seeking behavior; timely access to treatment; and appropriate
treatment of fever, diarrhea and, suspected pneumonia
among the target group of ill children aged 2–59 months. In
addition, access, quality of care, level of community accept-
ability, and utilization over time were measured to document
the program implementation.
MATERIALS AND METHODS
Program design, study setting, and participants. Kono,
a rural district bordering Guinea, has gold and diamond re-
sources that made it a strategic area during the war. IRC
implemented iCCM in Kono in September 2009; the program
becamealignedwith the 2012 national policy.19 A high density
model was used with a ratio of one CHW to 300–400 pop-
ulation (or to 35–50 children under-ﬁve) with CHWs based in
each village providing care at all times of day. Communities
selected their own CHWs to be as accessible as possible.
IRC trained CHWs and supplied them with medications
(artemisinin-based combination therapies [ACTs] for fever,
cotrimoxazole for suspected pneumonia, and oral rehydration
solution [ORS] and zinc for diarrhea), as per the national
policy.19 CHWs treated the three diseases among children
2–59 months but did not cover other aspects of community
health such as reproductive health and nutrition. Peer super-
visors, former CHWs who are literate and performed well as
CHWs, supervisedeight to 16CHWs.Onamonthly basis, they
conducted a home visit and used a checklist to assess CHW
performance regarding their ability to assess a child’s re-
spiratory rate, recall danger signs, and conduct a patient visit.
Peer supervisors used the visit to review and collect data from
the patient and drug registers, and to meet with community
members to hear their perspectives on the CHW’s perfor-
mance. They were formally supervised by the PHU in-charge
and received additional supervision froman IRChealth ofﬁcer.
Peer supervisors replenished medicines twice a month at the
monthly meetings at the PHU, based on the previous month’s
consumption by the CHW, and during supervision visits. They
carried a small quantity ofmedicines in their backpack, so that
theywere able to replenishmedicines whenever the CHWhad
a stock-out. There were 68 PHU catchment areas with 51,000
children under-ﬁve, supported by 831 CHWs in 14 chiefdoms
in the study area. The study participants were children under-
ﬁve years and persons ﬁve years and older.
Study design. Given that this was a real time evaluation of
an existing child health program, decisions on the study de-
signwere limited by logistical and ethical issues. At the project
design stage, the IRC did not plan for a baseline survey and
relied on the baseline mortality estimates from a survey
completed in 2007 for a smaller child survival program.20 After
implementation had begun, a midterm survey was planned in
which the evaluation teamwanted to account for lack of both a
baseline and a control group. A traditional control group was
not considered; based on the positive evidence supporting
iCCM, it was expected that the intervention would be beneﬁ-
cial rather than harmful andwithholding the interventionwould
be unethical.21–23 Furthermore, other districts were exposed
to iCCM or were not similar enough at baseline to serve
as a control. Therefore, a semirandomized stepped wedge
design was used at midterm (1 year postimplementation)
to derive baseline (preimplementation) and midterm (post-
implementation) estimates of mortality. Based on the ap-
pearance of a stable trend in treatment rates, full strength
implementation was achieved by June 2011. For the baseline
mortality rates, the person-days started 1 year before the date
of survey administration (September 22, 2009) up to the day
prior to the start of the intervention date in the individual’s
village. For the midterm (postimplementation) mortality rates,
the person-days started at the beginning of the intervention
date in an individual’s village and ended on the day of survey
administration (betweenOctober 11 andNovember 12, 2010).
However, in this paper only themidterm results mortality rates
are reported and compared with the endline mortality rates.
See Figure 1 for a timeline of implementation and surveys. The
lack of full randomization was necessitated, as there was an
ethical imperative to provide care ﬁrst to the worst-off areas.
Geographical areaswere randomly selected from lowandhigh
health-care access groups, as the iCCM program was ﬁrst
implemented in PHU catchment areas with little to no access
to health-care (i.e., no PHU, hospital, clinic, or pharmacy
present, the distance to a PHU, hospital, clinic, or pharmacy
was greater than one hour walking distance, nomotorbikes or
vehicles in the village, if the village was not a local trading
center, and if the majority of the villagers were farmers), fol-
lowed by those areas with greater access to health care.
We assessedwhether the expected changes occurred after
the implementation of iCCM. Multistage cluster household
surveys were administered during the midterm period in 2010
and at endline period in 2013 (after an average of 8 and
34 months of implementation, respectively). The sampling
frame was constructed using the number of households per
village based on a previous exhaustive survey in Kono for
onchocerciasismass drug administration and further updated
with the IRC’s programmatic data. The total number of
households per villagewas used as ameasure of size. Villages
(clusters) were the primary sampling unit with some larger
villages being divided into more than one sampling unit. In the
midterm, forﬁrst stageselection, thesamplewasstratiﬁed into
24 PHU catchment areas. Four clusters were chosen from
FIGURE 1. Timeline of the program implementation and evaluation, 2009–2013.
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each PHU stratum proportional to the number of households,
resulting in96clusters (midterm) and90clusters (endline). Asa
recall period for mortality of 12 months was used, at midterm,
villageswithmore than6monthswithout implementationwere
oversampled to ensure sufﬁcient exposure time for pre-
implementation, and small villages were oversampled to en-
sure that theywould not be excluded. At endline, the approach
was modiﬁed; villages were classiﬁed as small (£ 25 house-
holds), medium (26 to 50 households), or large (> 50 house-
holds), and villages with fewer than ﬁve households were
excluded. Clusters were chosen from each stratum to reﬂect
the distribution of village sizes in the sample. Medium and
large villages were oversampled to decrease ﬁeld visits. A
household was deﬁned as a group of people sleeping in the
same structure or group of structures during the previous
night and eating from the same cooking pot. In both midterm
and endline surveys, second stage selection of households
used one of two methods depending on the cluster size:
1) exhaustive sampling for clusterswith a number of households
which was equal or smaller than the expected sample size or
2) segmentation, if larger than expected. Speciﬁcally for the
module on childmorbidity, systematic random samplingwas
applied in addition to the second stage selection of house-
holds to select a subset of 13 households with children under-
ﬁve from the larger sample in each cluster. Data were collected
on all children under-ﬁve in the selected households. If there
was no child under-ﬁve living in that household, the next
household in the sampling plan was selected. Respondents
were deﬁned as mothers or caregivers of children under-ﬁve.
Study size. The sample size for the midterm survey was
6,067 households and was calculated to estimate the change
in under-ﬁve mortality from preintervention to the midterm.
The sample size was based on an estimated 30% reduction
from preintervention to midterm of U5MR from a preinter-
vention U5MR of six deaths per 1,000 children under-ﬁve per
month,20 alpha of 0.05, power of 80%, mortality recall period
of 12 months, design effect of 1.5, and a response rate of
90%. The proportion of children under-ﬁve was estimated at
17% and the average household size was estimated at six,
with one child under-ﬁve per household.17 Of the morbidity
indicators, the largest sample size requiredwas 1,248 children
or 13 children per village based on 95% CIs (±10%) and a
design effect of 2. This was used as the sample size for the
remaining indicators. The sample size for the endline survey
was 5,125 households and was calculated to statistically
detect an expected 28% decline in U5MR between the mid-
term and endline surveys (updated to 5,162 households as the
selected clusters contained this number of households).
Training and data collection. Enumerators spoke a com-
bination of multiple languages (Krio, Kono, Temne, Mende,
and Fula). Each team that administered the questionnaire at a
household consisted of an enumerator and a notetaker. Su-
pervisors oversaw two to four teamsduring data collection in a
single cluster. A 1-week training covered questionnaire ad-
ministration, role-playing, and ﬁeld testing. Supervisors were
responsible for adherence to second stage samplingmethods
and assuring questionnaire completeness at the cluster. If a
respondent was absent, the household was revisited twice on
the same day or the following day. At the village level, if more
than 15%of the householdswere absent, the team returned at
a later date. Refusals or absences were not replaced. Inves-
tigators reviewed all questionnaires twice. If responses were
found to be incomplete, the households were revisited.
Quantitative variables, data sources, measurements,
and bias. Before designing the midterm questionnaire, focus
group discussions with community members were held to
better understand the deﬁnition of a household and polyga-
mous families, orphans, multigenerational households; Krio
terminology and culturally relevant ways of obtaining infor-
mation on neonatal and child mortality, and signs, symptoms,
and severity of the three illnesses; understanding formal
and traditional sources of care, and perceptions of, and terms
used for CHWs. The morbidity questionnaire was developed
based on standard questions used in Demographic and
Health Surveys and further modiﬁed based on pilot testing.24
An appropriate provider was deﬁned as the PHU or CHW, and
an appropriate treatment was deﬁned as receiving ACT for
fever, ORS and zinc for diarrhea, and amoxicillin or cotri-
moxole for suspected pneumonia. The questionnaire was
translated into Krio and back-translated into English and ad-
ministered in Krio to an adult caregiver. For other languages,
the interviewer translated the questionnaire from Krio using a
list of speciﬁc standardized words that was reviewed during
the training ensuring that enumerators used the same termi-
nology. An events and agricultural calendar was used to
specify salient events that could help to recall time points
relevant to determine age andplacedeaths andevents in time.
The primary outcomes are described in Table 1.
TABLE 1
Primary outcomes measured by household survey
Factor Indicator
Care-seeking behavior Care seeking behavior from an appropriate provider by condition: proportion of ill children 2–59 months
who sought care from an appropriate provider (CHW or PHU).
Coverage of appropriate
treatment
Appropriate treatment froman appropriate provider (andCHWonly) by condition: proportion of ill children
2–59 months who sought care from an appropriate provider (CHW or PHU/CHW only), who received
ACT for fever, ORS, and zinc for diarrhea or amoxicillin or cotrimoxole for pneumonia.
Access to treatment Timely treatment within 24 hours of onset of symptoms.
Impact among target group
(and comparison groups)
Mortality rate amongchildren 2–59months:Number of children 2–59monthswhodied per 1,000 children
2–59 months per month.
Mortality rate among children under-ﬁve: Number of children under-ﬁve who died per 1,000 children
under-ﬁve per month.
Mortality rate among persons 5 years and older: Number of persons 5 years and older who died per 1,000
persons per month.
Community acceptability Recognition of the CHW: proportion of households whose respondent could correctly name the CHW.
Quality of care Correct case management: proportion of illnesses among children 2–59 months where the CHW
administered an appropriate treatment or referred child to a PHU.
ACT = artemisinin-based combination therapy; CHW = community health worker; ORS = oral rehydration solution; PHU = peripheral health unit.
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For the mortality questionnaire, a hybrid current and past
household census was undertaken in which all members
present at the start and endof the recall period aswell as births
and deaths were recorded to account for in- and out- migra-
tion.25 This used a recall period of 1 year to estimate age-
speciﬁc mortality rates for the target group (2–59 months of
age). Two groups were analyzed (under-ﬁve including those
less than 2 months of age; 5 years and over) to understand
background mortality estimates among the population that
iCCM was not intervening on. Given the high levels of in- and
out- migration in mining communities and other areas and the
need for precision around the exposure period to account for
the staggered program implementation, a hybrid household
census provided the most accurate accounting of exposure
time in the denominator. Age-speciﬁc mortality rates that
measure incidence of death over a 12-month recall period
were used instead of the previous birth history approach that
is typically used in national surveys. A previous birth history
tracks all births to a mother in her lifetime to produce the life-
time probability of dying before the age of ﬁve, regardless of
her place of residence inside or outside the program catch-
ment area.5,25 Age-speciﬁc mortality rates were used as the
programwasapplied toa speciﬁccatchment area, population,
time. Therefore, exposure to the programwould bemost likely
if a deﬁned limited recall period was used. The use of a limited
recall period also improves the accuracy of recall of the vital
events and their dates, whereas a full birth history has been
shown to substantially underestimate under-ﬁve mortality.5
After conducting the midterm survey, potential biases were
identiﬁed and addressed (see Table 2). The midterm results
indicated that communities in peri-urban settings were reliant
on health-care facilities and private clinics rather than CHWs;
therefore, the IRC stopped supporting iCCM in two peri-urban
areas (these clusters were removed from themidterm analysis
and the endline sampling frame). During the midterm, re-
spondents identiﬁed medicines received by pointing to pic-
tures of the iCCM drugs, whereas actual samples of blister
packs of drugs used by iCCM and blister packs and bottles
used by the PHUswere shown to respondents at endline. The
case deﬁnition for suspected pneumonia at midterm required
caregivers to spontaneously report fast or difﬁcult breathing
when requested to describe the child’s symptoms. This pro-
duced very few suspected pneumonia cases. At endline, the
requirement for the caregiver to ﬁrst report fast or difﬁcult
breathing was modiﬁed to increase the sensitivity of the
case deﬁnition. Therefore, if a cough or cold were reported,
respondents were prompted about other symptoms including
fast breathing. Since the method of measuring suspected
pneumonia changed between rounds, the indicators are not
directly comparable and only the endline results for treatment
are reported in this paper.
Statistical methods. The data were entered into a Micro-
soft Access database using double entry and error checks.
SAS 9.3 (SAS Institute Inc., Cary, NC) andSUDAAN (Research
Triangle Institute, Research Triangle Park, NC) were used to
compute complex survey procedures to account for the sur-
vey sample weights, stratiﬁcation, and clustering. CIs (95%)
were computed using a t value with an alpha of 0.05 and a
degree of freedom equal to the number of clusters minus the
number of strata. Sampling weights were calculated to ac-
count for unequal probabilities of selection and nonresponse.
Weighted proportions were calculated for the morbidity-
related variables and to account for differences between
proportions of children under-ﬁve between rounds. Multiple
symptoms per child were reported and analyzed. To test for
signiﬁcant differencesbetweenmorbidity-related variables, χ2
tests were used. Mortality rates were calculated for the entire
recall period. The number of person-days started at the be-
ginning of the recall period, or when the individual joined the
household after that date, and were converted into months.
Person-days ended the day of the survey or exit from the
household by death or out-migration. To test signiﬁcance
between mortality rates, a t test of the linear contrast was
used.
Program implementation. Routine program data and ad-
ditional survey indicators were analyzed to document pro-
gram implementation.26 To address access to care during the
4-year project period, the yearly under-ﬁvepopulation toCHW
ratio (equivalent to, [under-ﬁve population/number of CHWs])
was sourced from routine program data and calculated and
compared with target of 35–50 children under-ﬁve. To assess
utilization over time, the treatment rate, or mean treatments
per under-ﬁve population per month by condition and by
source, were sourced from routine program data and ana-
lyzed for the period covered by the survey, October 2009 to
February 2013 (equivalent to, [number of treatments per
month/under-ﬁve population] × 1,000 children under-ﬁve).
Stata 14.0 (StataCorp LP, College Station, TX) was used to
calculate, by condition and source, the differences in means
using an unpaired t test and to assess the trend with linear
regression. To assess community recognition of the CHW,
survey data on the proportion of households that could
TABLE 2
Key differences between midterm and endline surveys
Midterm Endline
Objective Measure mortality change between preimplementation
to postimplementation phase
Measure mortality change between midterm and endline
Survey design Multistage cluster survey with a semirandomized,
stepped wedge component
Multistage cluster survey
Sample size 6,067 households, 96 clusters 5,125 households, 90 clusters
Stratiﬁcation PHU Small, medium, large villages
Sampling Sampled urban areas (excluded in the analysis) No urban areas sampled
Data collection Respondents referred to treatments using apicture card Respondents referred to treatments using samples of
actual treatments (bottles, blister packs)
Pneumonia case deﬁnition required that respondents
reported fast or difﬁcult breathing
Pneumonia case deﬁnition modiﬁed so that if a cough/fast
or difﬁcult breathing/cold were reported, respondents
were prompted about the other symptoms
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correctly report the name of the CHW providing iCCM was
assessed (Table 1). For quality of care, survey data on the
proportionof fever, diarrhea, andsuspectedpneumonia cases
whowere appropriatelymanaged among childrenwho sought
care from a CHW were analyzed (Table 1). Appropriate man-
agement included appropriate treatment of each condition, or
referral when the child was less than 2months, treatment was
unavailable or conditions were associated with danger signs.
Ethical review. The evaluation received ethical approval
from theOfﬁce of the Sierra Leone Ethics andScientiﬁc Review
Committee. The Centers for Disease Control and Prevention’s
Institutional Review Board determined the evaluation to be a
nonresearch activity. Oral informed consentwas obtained from
each respondent.
RESULTS
Participants. Data collection were undertaken between
October 11 and November 12, 2010, and January 26 and
February 20, 2013. At midterm, 96 of 96 clusters containing
5,257 households were surveyed. During the analysis phase,
two clusters containing 89 households were excluded be-
cause they were found to be outside of the project area. At
endline, 89 of 90 clusters containing 3,649 households were
surveyed. In error, one cluster was listed twice in the sampling
frame in two different, bordering chiefdoms. Two clusters
were found to be outside the intervention area and were
replaced randomlywith twoclusters from the samesize strata.
In both surveys, the primary reason for missing households
wassampling frameerrorswhere villagepopulation sizeswere
lower than expected. This resulted in a reduction to 86.6%and
70.7% of the target sample size in the midterm and endline
evaluations, respectively. During both surveys, 95% of the
visited households responded. The demographic character-
istics of the two survey samples were similar (Table 3).
Mortality. Including neonates not targeted by iCCM, the
U5MR did not change signiﬁcantly from the midterm to the
endline survey, from4.54 (95%CI: 3.47–5.60) to 3.95 (95%CI:
3.47–5.60) deaths per 1,000 children under-ﬁve per month,
respectively (P = 0.4). The mortality rates did not change sig-
niﬁcantly for the 2–59 months age group targeted by iCCM
(decreasing from 3.64 (95% CI: 2.79–4.49) to 2.88 (95% CI:
2.28–3.47) deaths per 1,000 per month in 2010 and 2013,
respectively) (P = 0.15; Table 4). Mortality rates among per-
sons 5 years and older not targeted by iCCM increased from
0.68 (95% CI: 0.54–0.81) deaths to 0.93 (95% CI: 0.75–1.11)
deaths per 1,000 persons ﬁve and over per month (P = 0.03,
37% increase [95% CI: 2.9–70.6]).
Coverage, care-seekingbehavior, timely treatment, and
appropriate treatment. All coverage indicators refer to chil-
dren 2–59 months of age. Among all ill children, the CHW
as the ﬁrst source of care remained unchanged: 52% (95%CI:
45.3–58.6) in 2010 and 50.9% (95% CI: 41.2–60.4) in 2013
(P = 0.85). The PHU as the ﬁrst source of care decreased from
30% (95% CI: 24.8–35.9) to 21.7% (95% CI: 17.4–26.8) (P =
0.02). Taken together, the ﬁrst source as an appropriate pro-
vider (CHWor PHU) decreased from 82% (95%CI: 75.8–86.9)
to 72.6% (95% CI: 64.0–79.7) (P = 0.03). The proportion of ill
children for whom no treatment was sought remained similar
at 3.9% (95%CI: 2.1–7.3) in 2010 and 4.7% (95%CI: 3.0–7.4)
in 2013 (P = 0.63). At endline, a treatment (either appropriate
ornotappropriate)wasreceivedwithin24hours forapproximately
83% (95% CI: 77.8–87.1) of fever episodes, 82.9% (95% CI:
67.4–91.9) ofdiarrheaepisodes, and78.8%(95%CI: 66.0–87.7)
of suspected pneumonia episodes.
Table 5 presents the care-seeking and coverage indicators
by condition. There was a decrease in the proportion of chil-
dren with fever who sought treatment from an appropriate
provider, from 83.2% (95% CI: 76.7–88.2) in 2010 to 72.4%
(95% CI: 62.6–80.5) in 2013 (P = 0.02). Appropriate treatment
of fever fromanappropriate provider andCHW increased from
45.5% (95% CI: 39.2–52) to 58.2% (95% CI: 50.5–65.5) (P =
0.01) and 31.9% (95% CI: 26.7–37.6) to 44.4% (95% CI:
36.2–52.8) (P = 0.01), respectively. Care-seeking for diarrhea
from an appropriate provider remained consistently high
across rounds (87.3% [95% CI: 70.3–95.3] and 83.0% (95%
CI: 68.6–91.6]). Appropriate treatment from an appropriate
provider for diarrhea did not increase signiﬁcantly and was
28.9% (95% CI: 14.2–50) at baseline and 44.6% (95% CI:
33.9–55.8) at endline, nor from the CHW, at 27.9% (95% CI:
13.2–49.5) at baseline and 38.8% (95% CI: 27.2–51.8) at
endline. At endline, care-seeking fromappropriate provider for
suspected pneumonia was 86.7% (95% CI: 66.8–95.5) and
appropriate treatment from an appropriate provider and the
CHW was 58.8% (95% CI: 41.1–74.5) and 40.0% (95% CI:
25.4–56.6), respectively. We considered the sample sizes for
pneumonia at midterm to be too small to test for signiﬁcant
differences. The relative contributions of CHWs and PHUs to
appropriate treatment are shown inFigure 2.At endline,CHWs
contributed 76.2%, 87.0%, and 68.0% of all appropriate
treatments delivered for fever, diarrhea, and suspected
pneumonia, respectively.
Program implementation. In terms of access, the average
population under-ﬁve to CHW ratio increased from 38 (2009)
to 67 (2013), higher than the anticipated ratio of 35–50. For
utilization, there are considerable variability in the data. CHWs
had mean treatment rates that were 10–36 treatments per
under-ﬁve population per month higher than of PHUs across
all conditions from October 2009 to February 2013 (all con-
ditions, P < 0.001; Table 6). Figure 3A–C show a more stable
trend in monthly treatment rates for fever toward the midpoint
of the program, and some consistency in diarrhea treatments
amongCHWs that are generally higher than that of PHUs. The
trend for monthly suspected pneumonia treatment rates
among CHWs descends in contrast to an ascending trend
among PHUs. For recognition of the CHW, the survey results
showed there was an increase in recognition of the CHW from
57.5% to 82.4% (P < 0.005) households who could name the
CHWwithout prompting. For quality of care, the proportion of
ill children who were appropriately managed by the CHWs
increased from 62.4% (95% CI: 55.4–68.9) to 83.6 (95% CI:
79.1–87.2) (P < 0.001).
TABLE 3
Demographic characteristics, 2010 and 2013
Midterm Endline
Demographics N N
Number of households 5,257 3,649
Population recorded 32,808 28,914
Children under-ﬁve years
(% of total population)
5,257 (16%) 3,869 (16.4%)
Mean household size 6.7 6.6
Mean number of children
under-ﬁve per household
1.7 1.6
968 RATNAYAKE AND OTHERS
DISCUSSION
This program evaluation examined the effects of a high-
density iCCM program on care-seeking behavior, timely
treatment, appropriate treatment, and mortality among chil-
dren under-ﬁve in Kono district, a rural, postconﬂict area with
lowaccess to care. Utilization of theCHWas the ﬁrst source of
care remained at 50% in both rounds. However, the already
high proportion of households that could correctly name
the CHW without prompting increased from 58% to 82%. At
endline, 73% of ill children ﬁrst sought care from either the
CHW or PHU, which decreased from 82% at midterm. The
decrease was likely driven by a decrease in seeking care from
the PHU from midterm to endline. At endline, the receipt of
timely treatment was high across conditions (80%), however,
the ratio of CHWs to children (1:67) fell below the target (1:50)
but remained at the low end of the range calculated in a
study of 15 iCCM programs (mean 328; median 94; range
35–2,007).27 Taken together, this indicates that the program
provided timely and widely distributed access to treatment. In
terms of quality of care, 84% of all conditions were appropri-
ately managed at endline compared with 62% at midterm,
signaling that the capacity to manage cases improved. The
survey-basedcoverageestimatesarebackedbymeanmonthly
treatment rates by CHWs that were 10–36 treatments per
under-ﬁve population per month higher than that of PHUs.
At 72% (fever), 83% (diarrhea), and 87% (pneumonia) at
endline, care-seeking from an appropriate provider is con-
siderably higher than that demonstrated during another
endline survey evaluating care-seeking from appropriate
providers for all conditions in Kambia and Pujehun districts of
Sierra Leone (57.1%).28 It is notable that this evaluation
identiﬁed a high proportion of children with fever across both
rounds (34% and 49%) accompanied by a signiﬁcant 13%
point increase from 45% to 58% in the coverage of appro-
priate treatment of fever from an appropriate provider. CHWs
TABLE 5
Number and proportion of ill children receiving treatment within 24 hours of symptom onset and number and proportion of ill children seeking and
receiving treatment from an appropriate provider (CHW or government clinic), 2010 and 2013
Total children
Midterm Endline
P value
N = 1,226 N = 904
N % (95% CI) N % (95% CI)
Fever 415 81.6 (76.6–85.7) 439 75.5 [70.8–79.7] 0.06
Received any treatment £ 24 hours of
symptom onset
334 79.4 (73.4–84.4) 367 83 (77.8–87.1) 0.34
Sought treatment from appropriate
provider
350 83.2 (76.7–88.2) 344 72.4 (62.6–80.5) 0.02
CHW/PHU
Appropriate treatment* 200 45.5 (39.2–52) 273 58.2 (50.5–65.5) 0.01
CHW
Appropriate treatment* 148 31.9 (26.7–37.6) 219 44.4 (36.2–52.8) 0.01
Diarrhea 48 8.7 (6.5–11.7) 90 15 (11.9–18.8) 0.003
Received any treatment £ 24 hours of
symptom onset
42 91.7 (80.1–96.8) 79 82.9 (67.4–91.9) 0.18
Sought treatment from appropriate
provider
42 87.3 (70.3–95.3) 78 83 (68.6–91.6) 0.6
CHW/PHU
Appropriate treatment* 15 28.9 (14.2–50) 47 44.6 (33.9–55.8) 0.18
CHW
Appropriate treatment* 14 27.9 (13.2–49.5) 44 38.8 (27.2–51.8) 0.37
Pneumonia† 6 ‡ 76 13.1 (9.9–17.1) †
Received any treatment £ 24 hours of
symptom onset
3 ‡ 60 78.8 (66–87.7) †
Sought treatment from appropriate
provider
5 ‡ 68 86.7 (66.8–95.5) †
CHW/PHU
Appropriate treatment* 0 0 49 58.8 (41.1–74.5) †
CHW
Appropriate treatment* 0 0 36 40 (25.4–56.6) †
ACT = artemisinin-based combination therapy; CHW = community health worker; PHU = peripheral health unit.
* Appropriate treatment indicates ACT (fever), ORS and zinc (diarrhea), amoxicillin or cotrimoxazole (pneumonia).
†We consider the sample sizes too small to ascertain a signiﬁcant difference.
‡ Numbers too small to calculate.
TABLE 4
Under-ﬁve mortality rates, 2–59 month mortality rates and 5 years and over mortality rates, 2010 and 2013
Mortality
Midterm Endline Change
Mortality rate (95% CI)* DEFF Deaths N (persons) Mortality rate (95% CI)* DEFF Deaths N (persons) % Change P value
0–59 months* 4.54 (3.47–5.60) 2.27 146 3,466 3.95 (3.06–4.83) 1.99 184 3,869 _13% (_43.2 to 17.2) 0.4
2–59 months* 3.64 (2.79–4.49) 1.86 116 3,313 2.88 (2.28–3.47) 1.27 143 3,665 _21% (_49.5 to 7.7) 0.15
³ 5 years* 0.68 (0.54–0.81) 1.86 131 17,375 0.93 (0.75–1.11] 2.09 213 20,045 +37% (2.9 to 70.6) 0.03
CI = conﬁdence interval; DEFF = design effect.
* Rate is per 1,000 persons per month.
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contributed to 44%of the 58%of the coverage of appropriate
treatment of fever at endline, the larger proportion versus
PHUs. The coverage of appropriate treatment of suspected
pneumonia was nearly 60% at endline, with CHWs contrib-
uting 40%of the60%. In contrast, the coverageof appropriate
treatment at endline for diarrhea was low at 45%, though
CHWs provided 39% of the 45%. The lower diarrhea treat-
ment estimates are similar to lower than anticipated diarrhea
treatments from diverse settings including Coˆte d’Ivoire,
Rwanda, and South Sudan.29 Low numbers of diarrhea cases
were found in the midterm and endline surveys, which may
indicate poor reporting of diarrhea from the community. This
possibly results from a belief that diarrhea is not life-
threatening and the complex and incorrect understandings
of causation and the prevention of diarrhea.29,30Nevertheless,
at endline, the measured coverage of appropriate treatment
were not as high as the care-seeking estimates. This is likely
due to measurement error related to the caregivers not being
able to recall accurately the exact treatments used by CHWs
and PHUs based on viewing sample blister packs and bottles
at the time of survey administration.31 As well, PHUs and
CHWs may not have given appropriate treatments for a given
condition. However, CHWs are only stocked with appropriate
treatments, making this possibility less likely. Alternative ex-
planations are not supported by routine data; during the 2-
weekmorbidity recall period for the endline survey, there were
nomissingCHWsand the percentage of CHWs reporting a full
stock of drugs was 100% (Ratnayake R, unpublished data).
Overall, the proportions of appropriate treatment achieved for
all conditions are comparable for fever and higher for other
conditions than those seen in the iCCM-treatment group in a
recent evaluation of iCCM in Central Uganda (64.3%, fever;
28.8%, pneumonia; 15.9% diarrhea).32
Overall, the U5MR detected was lower than expected. The
13% decline in mortality rates for children under-ﬁve was not
statistically signiﬁcant. This result remains inconclusive as the
sample size was not powered to detect a relative change
smaller than 28% and the U5MR across rounds was lower
than anticipated. This is a result of logistical and ﬁnancial
constraints common to evaluating in real time child health
programs, where it is unfeasible to use the very large sample
sizes needed to account for the short implementation periods
inwhich to accumulate a rare event likedeaths.10However,we
found that the trends in timely and equitable access, appro-
priate treatment, quality of care, community recognition of the
CHW, and utilization over time showed the expected prog-
ress, indicating that the reduction of morbidity is likely. There
were also decreases in severe acute malnutrition in Kono
during the same period from 3.9% (2010) to 1.1% (2013),
which are congruent with lower child mortality.17,33 Of note,
mortality among persons 5 years and older increased signiﬁ-
cantly by 37%. Adult mortality rates have been decreasing in
Sierra Leone and other African countries, whereas maternal
mortality remainshigh inSierraLeone.34,35Evenwith the increase
in mortality among persons 5 years and older observed in the
endline survey, the CIs of the midterm CMR (0.46/10,000/day,
95%CI: 0.38–0.53) and endline CMR (0.41/10,000/day, 95%
CI: 0.34–0.48) overlap with the Sphere Project’s baseline
CMR for sub-Saharan Africa (0.41/10,000/day).36 The recall
period of the endline survey coincidedwith a national cholera
outbreak in which Kono was affected.37,38 However, we did
not carry out a verbal autopsy to determine the causes of
death which may have been helpful for developing a hy-
pothesis about potential causes and demographic groups
contributing to this increase.
TABLE 6
Mean treatment rates for CHWs and health facilities, October 2010 to
February 2013
PHU CHW Difference P value*
Fever 44.7 64.0 19.3 0.0017
Diarrhea 12.4 48.3 35.9 0.0000
Pneumonia 26.7 36.8 10.1 0.0007
CHW = community health worker; PHU = peripheral health unit.
* Unpaired, two-tailed t test for two samples.
FIGURE 2. Relative contribution of CHWs and peripheral health units (PHUs) to delivery of appropriate treatment, 2010 and 2013.
970 RATNAYAKE AND OTHERS
It is notable that several other evaluations of scaled iCCM
programs inBurkina Faso, Ethiopia, andMalawi over the same
implementation period have not demonstrated meaningful
increases in care-seeking and coverage of appropriate treat-
ments.11,12,15 This was related to program inputs and con-
textual factors that affected coverage and impact.39 It is
therefore useful to note that the ﬁndings of themidterm survey
led to improvements in program implementation. First, as part
of the investigation into the mortality estimates, an audit into
drug availability among CHWs between September 2009 and
November 2010 found thatCHWswereprovided a set amount
of drugs that did not match demand, resulting in regular drug
stock-outs in villages. Owing to central stock-outs in Kono or
inefﬁcient re-supply of CHWstocks, ACT, co-trimoxazole and
ORS and zinc were available, respectively, during 45%, 68%,
and 69% of the total days (Ratnayake R, unpublished data).
Given that malaria contributes substantially to the burden of
disease, it is likely that the stock-out levels had a substantial
negative impact on child mortality during the postintervention
period. As a result, the IRC tripled the drug supply to CHWs,
and continually restocked CHWs based on the previous
month’s consumption. Supervisors also beganmonitoring the
risk of CHWs not having enough medicine to provide a com-
plete treatment of 24 hours. Second, early in the project cycle,
detection of CHWs’ overtreatment of simple cough in children
led to corrective efforts to minimize antibiotic treatment of
cough; this may help to explain the decrease in treatment by
CHWs of suspected pneumonia over time. Third, CHWs were
withdrawn from peri-urban areas, and the community that
immediately surrounds PHUs as data showed a low utilization
on CHWs in these areas. Locations of CHWs were remapped
to ensure that all hard to reach areas had a CHW, and re-
sources were focused on the hardest to reach areas.
There are several important limitations to this evaluation.
The drug stock-outs likely led to higher child mortality rates in
thepostimplementation period,making them lesscomparable
with the preimplementation period. Therefore, we chose to
compare midterm (postimplementation) and endline mortality
rates and to exclude the preimplementation baselinemortality
rates. In addition, without a baseline survey of morbidity, we
can only compare endline (full intervention) with midterm
(medium strength intervention) coverage estimates. There-
fore, it is possible that the measurement of larger effects of
iCCMwasmissed. The sampling framecontained instancesof
erroneous village sizes that contributed to a 30% reduction in
sample size at the endline. Since the method of measuring
suspected pneumonia changed between rounds, the indi-
cators are not directly comparable and few cases were
detected at midterm. However, problems with the discrim-
inative power and speciﬁcity of the suspected pneumonia
case deﬁnition have been recognized and there is currently
no solution for producing valid treatment rates.40,41 Surveys
are subject to difﬁculties with accurate recall of the source
of care and types of treatments.42 To minimize this effect,
we asked caregivers to recall whether the provider carried a
drug box with the IRC logo. We asked caregivers to identify
treatments without prompting by using pictures (at mid-
term) or packages (at endline) from the array of all treat-
ments to avoid the misspeciﬁcation of treatments caused
by the interviewer reading out a list of treatments. Using our
approach, the two treatments administered for diarrhea
(ORS and zinc) that signify appropriate treatment may have
FIGURE 3. (A–C). Treatment rate and linear trend for fever, diarrhea,
and pneumonia, per 1,000 children under-ﬁve and by month, admin-
istered by CHWs and PHUs, October 2010–February 2013. (A) Fever.
(B) Diarrhea. (C) Pneumonia. CHW= community health worker; PHU=
peripheral health unit.
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been difﬁcult to identify jointly and therefore left out of the
numerator.43 Differences between the two surveys (small
villages oversampled in midterm and large villages over-
sampled in endline) may impact results. The length of time
for implementation between surveys was too short to see
very large changes in mortality (although there was a fairly
large but nonsigniﬁcant decrease noted). Finally, the pro-
grammatic data is limited by the availability of accurate
population data and data quality issues inherent to data
collected routinely.29
Rehabilitation of health systems in the postconﬂict period
can beneﬁt from community-based approaches. The 2014–
2016Ebolaoutbreakalsodemonstrated thepotential forCHWs
to enable more resilient health systems through their inherent
roles in mobilizing and engaging their own communities and in
extending surveillance to the village level.44–46 iCCMcontinues
to be a realistic strategy to reducing the treatment gap for
children in the most rural and hard to reach areas of Kono
District. Lower than anticipated diarrhea treatment rates should
be addressed and efforts to increase care-seeking at both the
CHW and PHU level should be undertaken. Overall, iCCM
provides a counterpart to the Free Health Care Initiative as it
overcomes barriers of access to health facilities and provides
insurance against the national stock-out of medicines.
Received January 16, 2017. Accepted for publication April 19, 2017.
Published online June 12, 2017.
Acknowledgments: We would like to thank the IRC and Sierra Leone
Ministry of Health and Sanitation staff who carry out the work to keep
the iCCM program running; the enumerators who worked carefully
and thoroughly; supervisors and logisticians who assured quality
control (Stephanie Alfaro, Ayman Assa, Amy Callis, Hassan Kamara,
Samira Sami, Julia Smith, and Jen Ziegler); Paul Amendola for assis-
tance with data management and Emmanuel d’Harcourt for key in-
formation about the initial implementation of the program.
Financial support: The work presented in the paper was completed
primarily with funds from the Canadian International Development
Agency (Global Affairs Canada) with substantial additional support
from the United States Agency for International Development and
UNICEF.
Disclaimer: The ﬁndings and conclusions in this report are those of the
authors and do not necessarily represent the ofﬁcial position of the
Centers for Disease Control and Prevention.
Authors’ addresses: Ruwan Ratnayake, Laura Miller, and Yolanda
Barbera, Health Unit, International RescueCommittee, NewYork, NY,
E-mails: ruwan.ratnayake@rescue.org, laura.miller@rescue.org, and
yolanda.barbera@rescue.org. Mary Choi, Viral Special Pathogens
Branch, Division of High Consequence Pathogens and Pathology,
Centers for Disease Control and Prevention, Atlanta, GA, E-mail:
whz2@cdc.gov. Jeffrey Ratto, Colleen Hardy, and Curtis Blanton,
EmergencyResponseandRecoveryBranch,DivisionofGlobalHealth
Protection,Center for Global Health, Centers for Disease Control and
Prevention, Atlanta, GA, E-mails: itt4@cdc.gov, diz2@cdc.gov, and
cgb9@cdc.gov. John Kpaleyea and Pheabean Momoh, International
RescueCommittee, Freetown, Sierra Leone, E-mails: john.kpaleyea@
rescue.org and pheabean.momoh@rescue.org.
This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the
original author and source are credited.
REFERENCES
1. YouD, Hug L, Ejdemyr S, Idele P, HoganD,Mathers C, GerlandP,
NewJR, AlkemaL;UnitedNations Inter-agencyGroup forChild
Mortality Estimation, 2015. Global, regional, and national levels
and trends in under-5 mortality between 1990 and 2015, with
scenario-based projections to 2030: a systematic analysis by
the UN Inter-agency Group for Child Mortality Estimation.
Lancet 386: 2275–2286.
2. UNICEF and WHO, 2015. Countdown to 2015: A Decade of
Tracking Progress for Maternal, Newborn and Child Survival:
The 2015 Report. New York, NY: UNICEF and Geneva,
Switzerland: WHO.
3. Bertone MP, Samai M, Edem-Hotah J, Witter S, 2014. A window
of opportunity for reform in postconﬂict settings? The case
of human resources for health policies in Sierra Leone,
2002–2012. Conﬂict Health 8: 11.
4. Fornah JS, Macarthy P, Sawaneh ST, Sillah A, Nandy R, Roberts
L, 2001. Mortality In Kenema District, Sierra Leone: A Survey
Covering Jan. 2000–Jan. 2001. Freetown, Sierra Leone: In-
ternational Rescue Committee.
5. Checchi F, Roberts L, 2005. Interpreting and Using Mortality
Data in Humanitarian Emergencies: A primer for Non-
Epidemiologists. Network Paper Humanitarian Practice. London,
UK: Overseas Development Institute.
6. MaxmenA, 2013.Sierra Leone’s free health-care initiative:work in
progress. Lancet 381: 191–192.
7. Witter S, Wurie H, Bertone MP, 2016. The free health care initia-
tive: how has it affected health workers in Sierra Leone?Health
Policy Plan 31: 1–9.
8. Ministry of Health and Sanitation, 2009. National Health Sector
Strategic Plan 2010–2015. Freetown, Sierra Leone: Government
of Sierra Leone.
9. WHO, UNICEF, 2012. WHO/UNICEF Joint Statement on In-
tegrated Community Case Management (iCCM): An Equity-
Focused Strategy to Improve Access to Essential Treatment
Services for Children. Geneva, Switzerland: World Health Or-
ganization and New York, NY: UNICEF.
10. Amouzou A, Morris S, Moulton LH, Mukanga D, 2014. Assessing
the impact of integrated community case management (iCCM)
programs on child mortality: review of early results and lessons
learned in sub-Saharan Africa. J Glob Health 4: 020411.
11. Amouzou A, Hazel E, ShawB,Miller NP, TafesseM,Mekonnen Y,
Moulton LH, Bryce J, Black RE, 2016. Effects of the integrated
community case management of childhood illness strategy on
childmortality in Ethiopia: a cluster randomizedTrial.AmJTrop
Med Hyg 94: 596–604.
12. AmouzouA, et al., 2016. Independent evaluation of the integrated
community case management of childhood illness strategy in
Malawi using a National Evaluation PlatformDesign.Am J Trop
Med Hyg 94: 574–583.
13. Daelmans B, Seck A, Nsona H, Wilson S, Young M, 2016. In-
tegrated community case management of childhood illness:
what have we learned? Am J Trop Med Hyg 94: 571–573.
14. Diaz T, Aboubaker S, Young M, 2014. Current scientiﬁc evidence
for integrated community case management (iCCM) in Africa:
ﬁndings from the iCCM evidence symposium. J Glob Health 4:
020101.
15. Munos M, Guiella G, Roberton T, Maiga A, Tiendrebeogo A, Tam
Y, Bryce J, Baya B, 2016. Independent evaluation of the rapid
scale-up program to reduce under-ﬁve mortality in Burkina
Faso. Am J Trop Med Hyg 94: 584–595.
16. Kruk ME, Freedman LP, Anglin GA, Waldman RJ, 2010. Re-
building health systems to improve health and promote state-
building in post-conﬂict countries: a theoretical framework and
research agenda. Soc Sci Med 70: 89–97.
17. Statistics Sierra Leone (SSL) and UNICEF Sierra Leone, 2011.
Sierra Leone Multiple Indicator Cluster Survey 2010, Final
Report. Freetown, Sierra Leone: SSL and UNICEF.
18. World Health Organization. WHO Global Database on Child
Growth andMalnutrition. DepartmentofNutrition forHealth and
Development (NHD). Geneva, Switzerland: WHO. Available at:
http://www.who.int/nutgrowthdb/about/introduction/en/index5.
html. Accessed May 30, 2017.
19. Ministry of Health and Sanitation, 2012. Policy for Community
Health Workers in Sierra Leone. Freetown, Sierra Leone: Gov-
ernment of Sierra Leone.
972 RATNAYAKE AND OTHERS
20. IRC Child Survival Program, 2007. Community Based Treatment
Mortality Survey, 26 March–2 April 2007. Freetown, Sierra
Leone: IRC.
21. Chinbuah AM, Gyapong JO, Pagnoni F, Wellington EK, Gyapong
M, 2006. Feasibility and acceptability of the use of artemether-
lumefantrine in the home management of uncomplicated
malaria in children 6–59 months old in Ghana. Trop Med Int
Health 11: 1003–1016.
22. Sazawal S, Black RE, Pneumonia Case Management Trials G,
2003. Effect of pneumonia case management on mortality in
neonates, infants, and preschool children: a meta-analysis of
community-based trials. Lancet Infect Dis 3: 547–556.
23. Brown CA, Lilford RJ, 2006. The stepped wedge trial design: a
systematic review. BMC Med Res Methodol 6: 54.
24. U.S. Agency for International Development, 2011. Demographic
and Health Surveys Methodology—Questionnaires: House-
hold,Woman’s, andMan’s.MEASUREDHSPhase III. Calverton,
MD: International ICF.
25. Cairns KL,Woodruff BA,MyattM, Bartlett L, GoldbergH, Roberts
L, 2009. Cross-sectional survey methods to assess retro-
spectively mortality in humanitarian emergencies. Disasters
33: 503–521.
26. Habicht JP, VictoraCG,Vaughan JP, 1999. Evaluationdesigns for
adequacy, plausibility and probability of public health pro-
gramme performance and impact. Int J Epidemiol 28: 10–18.
27. Oliphant NP, Muniz M, Guenther T, Diaz T, Lainez YB, Counihan
H, Pratt A, 2014. Multi-country analysis of routine data from
integrated community case management (iCCM) programs in
sub-Saharan Africa. J Glob Health 4: 020408.
28. Yansaneh AI, Moulton LH, George AS, Rao SR, Kennedy N,
Bangura P, Brieger WR, Kabano A, Diaz T, 2014. Inﬂuence of
community health volunteers on care seeking and treatment
coverage for common childhood illnesses in the context of free
health care in rural Sierra Leone. Trop Med Int Health 19:
1466–1476.
29. Lainez YB, Wittcoff A, Mohamud AI, Amendola P, Perry HB,
D’Harcourt E, 2012. Insights from community case manage-
ment data in six sub-Saharan African countries.AmJTropMed
Hyg 87 (Suppl): 144–150.
30. McMahon SA, George AS, Yumkella F, Diaz T, 2013. Spoiled
breast milk and bad water; local understandings of diarrhea
causes andprevention in rural Sierra Leone.BMCPublicHealth
13: 1172.
31. Eisele TP, Rhoda DA, Cutts FT, Keating J, Ren R, Barros AJ,
Arnold F, 2013. Measuring coverage in MNCH: total survey
error and the interpretation of intervention coverage estimates
from household surveys. PLoS Med 10: e1001386.
32. Mubiru D, et al., 2015. Evaluation of integrated community case
management in eight districts of central Uganda.PLoSOne 10:
e0134767.
33. Statistics Sierra Leone , 2014. Sierra Leone Demographic and
Health Survey 2013. Rockville, MD: ICF International.
34. GBD Mortality Causes of Death Collaborators, 2015. Global,
regional, and national age-sex speciﬁc all-cause and cause-
speciﬁc mortality for 240 causes of death, 1990–2013: a sys-
tematic analysis for the Global Burden of Disease Study 2013.
Lancet (London, England) 385: 117–171.
35. GBD 2015 Maternal Mortality Collaborators, 2016. Global, re-
gional, and national levels of maternal mortality, 1990–2015: a
systematic analysis for the Global Burden of Disease Study
2015. Lancet 388: 1775–1812.
36. The Sphere Project, 2004. Humanitarian Charter and Minimum
Standards in Disaster Response. Oxford: Oxfam.
37. World Health Organization, 2012. Outbreak news. Cholera, Sierra
Leone.Wkly Epidemiol Rec 87: 337–338.
38. WHO Regional Ofﬁce for Africa, 2012. Sierra Leone: Cholera
(Situation as of 16 October 2012). Geneva, Switzerland: World
Health Organization.
39. Hazel E, Bryce J, 2016. Group I-JiEW. On bathwater, babies, and
designing programs for impact: evaluations of the integrated
community case management strategy in Burkina Faso,
Ethiopia, and Malawi. Am J Trop Med Hyg 94: 568–570.
40. Campbell H, El Arifeen S, Hazir T, O’Kelly J, Bryce J, Rudan I, Qazi
SA, 2013. Measuring coverage in MNCH: challenges in moni-
toring the proportion of young children with pneumonia who
receive antibiotic treatment. PLoS Med 10: e1001421.
41. Hazir T, et al., 2013.Measuring coverage inMNCH: a prospective
validation study in Pakistan and Bangladesh on measuring
correct treatment of childhood pneumonia. PLoS Med 10:
e1001422.
42. Bryce J, Arnold F, Blanc A, Hancioglu A, Newby H, Requejo J,
WardlawT, 2013.MeasurementCWGoIC.Measuring coverage
in MNCH: new ﬁndings, new strategies, and recommendations
for action. PLoS Med 10: e1001423.
43. Fischer Walker CL, Fontaine O, Black RE, 2013. Measuring cov-
erage in MNCH: current indicators for measuring coverage of
diarrhea treatment interventions and opportunities for im-
provement. PLoS Med 10: e1001385.
44. Perry HB, et al., 2016. Community health worker programmes
after the 2013–2016 Ebola outbreak. Bull World Health Organ
94: 551–553.
45. Ratnayake R, Crowe SJ, Jasperse J, Privette G, Stone E, Miller L,
Hertz D, Fu C, Maenner MJ, Jambai A, Morgan O, 2016. As-
sessment of community event-based surveillance for ebola virus
disease, Sierra Leone, 2015. Emerg Infect Dis 22: 1431–1437.
46. Kieny MP, Dovlo D, 2015. Beyond ebola: a new agenda for re-
silient health systems. Lancet 385: 91–92.
ICCM EVALUATION IN SIERRA LEONE 973
